Cargando…
The Current State of Charcot–Marie–Tooth Disease Treatment
Charcot–Marie–Tooth disease (CMT) and associated neuropathies are the most predominant genetically transmitted neuromuscular conditions; however, effective pharmacological treatments have not established. The extensive genetic heterogeneity of CMT, which impacts the peripheral nerves and causes life...
Autores principales: | Okamoto, Yuji, Takashima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379063/ https://www.ncbi.nlm.nih.gov/pubmed/37510296 http://dx.doi.org/10.3390/genes14071391 |
Ejemplares similares
-
Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009) -
Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan
por: Yoshimura, Akiko, et al.
Publicado: (2019) -
Charcot-Marie-Tooth Disease: Seventeen Causative Genes
por: Lee, Jung-Hwa, et al.
Publicado: (2006) -
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review
por: Yalcouyé, Abdoulaye, et al.
Publicado: (2022) -
Charcot-Marie-Tooth: From Molecules to Therapy
por: Morena, Jonathan, et al.
Publicado: (2019)